RxDoctor Payments Data

Michelle Bennett

Adolescent Medicine · Huntington Beach, CANPI 1598726507

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.1% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Pfizer at 30.7% of the total. Reporting peaked in 2020 at $365 and has fallen 85.5% since, to $53 in 2025.

$1,458in general payments, 2019–2025

Across 80 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$447
  • GSK$131
  • Phadia US Inc.$130
  • Merck$101
  • Kaleo, Inc.$98
  • Cranial Technologies, Inc$78
  • plus $471 from 17 others

What the payments were for

  • Food & beverage$1,44599%
  • Education$131%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,458 in reported general payments places this provider in the 85th percentile of 202 adolescent medicine providers in California.

See all adolescent medicine providers in California

Other adolescent medicine in Huntington Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →